Michelle Tanious

Improved detection of synthetic lethal interactions in Drosophila cells using variable dose analysis (VDA)

Reactive oxygen species, toxicity, oxidative stress, and antioxidants: chronic diseases and aging

Depression

Bipolar disorder

HIF-independent synthetic lethality between CDK4/6 inhibition and VHL loss across species

Royal Australian and New Zealand College of Psychiatrists clinical practice guidelines for mood disorders

The prevalence and management of side effects of lithium and anticonvulsants as mood stabilizers in bipolar disorder from a clinical perspective

Role of the Axonal Initial Segment in Psychiatric Disorders: Function, Dysfunction, and Intervention

Elevated levels of plasma brain derived neurotrophic factor in rapid cycling bipolar disorder patients

Transcription Factor NRF2 as a Therapeutic Target for Chronic Diseases: A Systems Medicine Approach

Oxidative Stress Implications in the Affective Disorders: Main Biomarkers, Animal Models Relevance, Genetic Perspectives, and Antioxidant Approaches

Therapeutic Potential of Mood Stabilizers Lithium and Valproic Acid: Beyond Bipolar Disorder

Assessment and management of behavioral and psychological symptoms of dementia

The Fibroblast Growth Factor signaling pathway

Lithiumeter: Version 2.0

Analysis of the Structural Diversity, Substitution Patterns, and Frequency of Nitrogen Heterocycles among U.S. FDA Approved Pharmaceuticals

Metallodrugs in Medicinal Inorganic Chemistry

Nutrition and bipolar disorder: a systematic review

Royal Australian and New Zealand College of Psychiatrists clinical practice guidelines for mood disorders: bipolar disorder summary

Exercise as medicine – evidence for prescribing exercise as therapy in 26 different chronic diseases

N‐acetylcysteine as an adjunctive treatment for bipolar depression: A systematic review and meta‐analysis of randomized controlled trials

Mania: Diagnosis and Treatment Recommendations

Potential Mechanisms of Action of Lithium in Bipolar Disorder

The lithiumeter: a measured approach

A randomised controlled trial of a mitochondrial therapeutic target for bipolar depression: mitochondrial agents, N-acetylcysteine, and placebo

Mixed state discrimination: A DSM problem that won׳t go away?

The Efficacy of AdjunctiveN-Acetylcysteine in Major Depressive Disorder

Optimal Frequency of Lithium Administration in the Treatment of Bipolar Disorder

Bordering on bipolar: The overlap between borderline personality and bipolarity

The science and practice of lithium therapy

Design and rationale of a 16-week adjunctive randomized placebo-controlled trial of mitochondrial agents for the treatment of bipolar depression